Keyword Connections

•  Agnes Fogo
•  Cassianne Robinson-Cohen
•  Charles Sanders
•  Edward Gould
•  Iekuni Ichikawa
•  Jorge Gamboa

•  Kelly Birdwell
•  Matthew Wilson
•  Ming-Zhi Zhang
•  Pinelopi Kapitsinou
•  Ray Harris
•  Richard Breyer

•  Ruey Hu
•  Ryan Hsi
•  T. Alp Ikizler
•  Volker Haase
•  W. Rathmell

Resources

• Advances in Research Conference for Kidney Week 2016
• Cardiovascular Pathophysiology & Complications Core List of Services
• Education & Outreach

Communities

• No matching connections

Publications

• APOL1 risk variants, race, and progression of chronic kidney disease.
  Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ, AASK Study Investigators, CRIC Study Investigators
  (2013) N Engl J Med 369: 2183-96
• Complement activation and hypersensitivity reactions to dialysis membranes.
  Hakim RM, Breillatt J, Lazarus JM, Port FK
  (1984) N Engl J Med 311: 878-82
• Rational use of analgesic and antiinflammatory drugs.
  Crofford LJ
  (2001) N Engl J Med 345: 1844-6
• Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
  Cancer Genome Atlas Research Network, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, Rathmell WK, Brooks AN, Hoadley KA, Robertson AG, Brooks D, Bowlby R, Sadeghi S, Shen H, Weisenberger DJ, Bootwalla M, Baylin SB, Laird PW, Cherniack AD, Saksena G, Haake S, Li J, Liang H, Lu Y, Mills GB, Akbani R, Leiserson MD, Raphael BJ, Anur P, Bottaro D, Albiges L, Barnabas N, Choueiri TK, Czerniak B, Godwin AK, Hakimi AA, Ho TH, Hsieh J, Ittmann M, Kim WY, Krishnan B, Merino MJ, Mills Shaw KR, Reuter VE, Reznik E, Shelley CS, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Tickoo S, Burnett K, Crain D, Gardner J, Lau K, Mallery D, Morris S, Paulauskis JD, Penny RJ, Shelton C, Shelton WT, Sherman M, Thompson E, Yena P, Avedon MT, Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, Santos T, Wise L, Zmuda E, Demchok JA, Felau I, Hutter CM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J, Ayala B, Baboud J, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Ally A, Balasundaram M, Balu S, Beroukhim R, Bodenheimer T, Buhay C, Butterfield YS, Carlsen R, Carter SL, Chao H, Chuah E, Clarke A, Covington KR, Dahdouli M, Dewal N, Dhalla N, Doddapaneni HV, Drummond JA, Gabriel SB, Gibbs RA, Guin R, Hale W, Hawes A, Hayes DN, Holt RA, Hoyle AP, Jefferys SR, Jones SJ, Jones CD, Kalra D, Kovar C, Lewis L, Li J, Ma Y, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Moore RA, Morton D, Mose LE, Mungall AJ, Muzny D, Parker JS, Perou CM, Roach J, Schein JE, Schumacher SE, Shi Y, Simons JV, Sipahimalani P, Skelly T, Soloway MG, Sougnez C, Tam A, Tan D, Thiessen N, Veluvolu U, Wang M, Wilkerson MD, Wong T, Wu J, Xi L, Zhou J, Bedford J, Chen F, Fu Y, Gerstein M, Haussler D, Kasaian K, Lai P, Ling S, Radenbaugh A, Van Den Berg D, Weinstein JN, Zhu J, Albert M, Alexopoulou I, Andersen JJ, Auman JT, Bartlett J, Bastacky S, Bergsten J, Blute ML, Boice L, Bollag RJ, Boyd J, Castle E, Chen YB, Cheville JC, Curley E, Davies B, DeVolk A, Dhir R, Dike L, Eckman J, Engel J, Harr J, Hrebinko R, Huang M, Huelsenbeck-Dill L, Iacocca M, Jacobs B, Lobis M, Maranchie JK, McMeekin S, Myers J, Nelson J, Parfitt J, Parwani A, Petrelli N, Rabeno B, Roy S, Salner AL, Slaton J, Stanton M, Thompson RH, Thorne L, Tucker K, Weinberger PM, Winemiller C, Zach LA, Zuna R
  (2016) N Engl J Med 374: 135-45
• Tolvaptan in patients with autosomal dominant polycystic kidney disease.
  Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, TEMPO 3:4 Trial Investigators
  (2012) N Engl J Med 367: 2407-18
• Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
  Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, Wieslander J, Kashtan C, Borza DB, Neilson EG, Wilson CB, Hudson BG
  (2010) N Engl J Med 363: 343-54
• Intensive blood-pressure control in hypertensive chronic kidney disease.
  Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X, AASK Collaborative Research Group
  (2010) N Engl J Med 363: 918-29
• Rapidly Progressive Renal Failure in a Young Woman.
  Scarpelli DG
  (1975) N Engl J Med 293: 922-7
• The effect of aprotinin on outcome after coronary-artery bypass grafting.
  Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF
  (2008) N Engl J Med 358: 784-93
• Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.
  Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ
  (1998) N Engl J Med 339: 1285-92
• Dialysis and transplantation in end-stage lupus nephritis.
  Ziff M, Helderman JH
  (1983) N Engl J Med 308: 218-9
• Hemodialysis.
  Himmelfarb J, Ikizler TA
  (2010) N Engl J Med 363: 1833-45
• Effect of the dialysis membrane in the treatment of patients with acute renal failure.
  Hakim RM, Wingard RL, Parker RA
  (1994) N Engl J Med 331: 1338-42
• Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.
  Arnaout MA, Hakim RM, Todd RF, Dana N, Colten HR
  (1985) N Engl J Med 312: 457-62
• Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
  Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ, Global ARCC Trial
  (2007) N Engl J Med 356: 2271-81
• Alport's syndrome, Goodpasture's syndrome, and type IV collagen.
  Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG
  (2003) N Engl J Med 348: 2543-56
• Sodium depletion enhances nephrotoxicity of amphotericin B.
  Feely J, Heidemann H, Gerkens J, Roberts LJ, Branch RA
  (1981) Lancet 1: 1422-3
• Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome.
  Watson ML, Gill JR, Branch RA, Oates JA, Brash AR
  (1983) Lancet 2: 368-70
• Increased lipid peroxidation in patients with rhabdomyolysis.
  Holt S, Reeder B, Wilson M, Harvey S, Morrow JD, Roberts LJ, Moore K
  (1999) Lancet 353: 1241
• Integrin-linked kinase is an adaptor with essential functions during mouse development.
  Lange A, Wickström SA, Jakobson M, Zent R, Sainio K, Fässler R
  (2009) Nature 461: 1002-6
• Trans-ethnic association study of blood pressure determinants in over 750,000 individuals.
  Giri A, Hellwege JN, Keaton JM, Park J, Qiu C, Warren HR, Torstenson ES, Kovesdy CP, Sun YV, Wilson OD, Robinson-Cohen C, Roumie CL, Chung CP, Birdwell KA, Damrauer SM, DuVall SL, Klarin D, Cho K, Wang Y, Evangelou E, Cabrera CP, Wain LV, Shrestha R, Mautz BS, Akwo EA, Sargurupremraj M, Debette S, Boehnke M, Scott LJ, Luan J, Zhao JH, Willems SM, Thériault S, Shah N, Oldmeadow C, Almgren P, Li-Gao R, Verweij N, Boutin TS, Mangino M, Ntalla I, Feofanova E, Surendran P, Cook JP, Karthikeyan S, Lahrouchi N, Liu C, Sepúlveda N, Richardson TG, Kraja A, Amouyel P, Farrall M, Poulter NR, Understanding Society Scientific Group, International Consortium for Blood Pressure, Blood Pressure-International Consortium of Exome Chip Studies, Laakso M, Zeggini E, Sever P, Scott RA, Langenberg C, Wareham NJ, Conen D, Palmer CNA, Attia J, Chasman DI, Ridker PM, Melander O, Mook-Kanamori DO, Harst PV, Cucca F, Schlessinger D, Hayward C, Spector TD, Jarvelin MR, Hennig BJ, Timpson NJ, Wei WQ, Smith JC, Xu Y, Matheny ME, Siew EE, Lindgren C, Herzig KH, Dedoussis G, Denny JC, Psaty BM, Howson JMM, Munroe PB, Newton-Cheh C, Caulfield MJ, Elliott P, Gaziano JM, Concato J, Wilson PWF, Tsao PS, Velez Edwards DR, Susztak K, Million Veteran Program, O'Donnell CJ, Hung AM, Edwards TL
  (2019) Nat Genet 51: 51-62
• Metal chelation and inhibition of bacterial growth in tissue abscesses.
  Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, Anderson KL, Dattilo BM, Dunman PM, Gerads R, Caprioli RM, Nacken W, Chazin WJ, Skaar EP
  (2008) Science 319: 962-5
• Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype.
  Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC
  (1995) Science 269: 230-4
• Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells.
  Zuber MX, Simpson ER, Waterman MR
  (1986) Science 234: 1258-61
• Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer.
  Liu J, Ghanim M, Xue L, Brown CD, Iossifov I, Angeletti C, Hua S, Nègre N, Ludwig M, Stricker T, Al-Ahmadie HA, Tretiakova M, Camp RL, Perera-Alberto M, Rimm DL, Xu T, Rzhetsky A, White KP
  (2009) Science 323: 1218-22
• Acute renal failure and rhabdomyolysis after ingestion of phenylpropanolamine-containing diet pills.
  Swenson RD, Golper TA, Bennett WM
  (1982) JAMA 248: 1216
• Assessing Toxicity of Intravenous Crystalloids in Critically Ill Patients.
  Kellum JA, Shaw AD
  (2015) JAMA 314: 1695-7
• High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
  Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ
  (2016) JAMA 315: 877-88
• Statins to Reduce Acute Kidney Injury After Cardiac Surgery--Reply.
  Billings FT, Brown NJ
  (2016) JAMA 316: 349-50
• Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.
  Kapur P, Peña-Llopis S, Christie A, Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ, Brugarolas J
  (2013) Lancet Oncol 14: 159-167
• HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma.
  Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, Flaherty KT, Rathmell WK, Keith B, Simon MC, Nathanson KL
  (2008) Cancer Cell 14: 435-46
• The somatic genomic landscape of chromophobe renal cell carcinoma.
  Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA, The Cancer Genome Atlas Research Network, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheeler DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ
  (2014) Cancer Cell 26: 319-330